Calcijex%252525252BIV
Adult Min/Max Dose: 0.209mcg/1.355mcg
Pediatric Min/Max Dose: 0.0040mcg/kg/0.08mcg/kg
Common Dosages:
inject 0.5 milliliter (0.5 mcg) by intravenous route 3 times per week
inject 1 milliliter (1 mcg) by intravenous route 3 times per week
inject 3 milliliters (3 mcg) by intravenous route 3 times per week
inject 0.5 milliliter (1 mcg) by intravenous route 3 times per week
inject 1.5 milliliters (3 mcg) by intravenous route 3 times per week
inject 0.25 milliliter (0.5 mcg) by intravenous route 3 times per week
inject 0.5 milliliter (0.5 mcg) by intravenous route 3 times per week
inject 1 milliliter (1 mcg) by intravenous route 3 times per week
inject 3 milliliters (3 mcg) by intravenous route 3 times per week
inject 1.5 milliliters (3 mcg) by intravenous route 3 times per week
inject 0.25 milliliter (0.5 mcg) by intravenous route 3 times per week
inject 0.5 milliliter (0.5 mcg) by intravenous route 3 times per week
inject 1 milliliter (1 mcg) by intravenous route 3 times per week
inject 3 milliliters (3 mcg) by intravenous route 3 times per week
inject 0.5 milliliter (1 mcg) by intravenous route 3 times per week
inject 1.5 milliliters (3 mcg) by intravenous route 3 times per week
inject 2 milliliters (4 mcg) by intravenous route 3 times per week
inject 0.25 milliliter (0.5 mcg) by intravenous route 3 times per week
inject 1 milliliter (1 mcg) by intravenous route 3 times per week
inject 1.5 milliliters (1.5 mcg) by intravenous route 3 times per week
inject 2 milliliters (2 mcg) by intravenous route 3 times per week
inject 0.5 milliliter (1 mcg) by intravenous route 3 times per week
inject 0.75 milliliter (1.5 mcg) by intravenous route 3 times per week
inject 1 milliliter (2 mcg) by intravenous route 3 times per week
inject 0.5 milliliter (0.5 mcg) by intravenous route 3 times per week
inject 1 milliliter (1 mcg) by intravenous route 3 times per week
inject 3 milliliters (3 mcg) by intravenous route 3 times per week
inject 0.5 milliliter (1 mcg) by intravenous route 3 times per week
inject 1.5 milliliters (3 mcg) by intravenous route 3 times per week
inject 0.25 milliliter (0.5 mcg) by intravenous route 3 times per week
All Labeled Uses: Hyperparathyroidism Secondary to Chronic Renal Failure, Hypocalcemia, Hypocalcemia from End-Stage Renal Disease with Dialysis, Hypoparathyroidism, Hypophosphatemia, Renal Osteodystrophy
Unlabeled Uses: Neonatal Hypocalcemic Tetany, Prevention of Vitamin D Deficiency, Rickets, Vitamin D Deficiency, Vitamin D Dependent Rickets, Vitamin D-Resistant Rickets
Moderate Interaction:
Assess the risk to the patient and take action as needed.
FAT SOLUBLE VITAMINS/ORLISTAT - Decreased effect of the former drug
Lactation
Precaution: USE NOT RECOMMENDED.
Pregnancy
Only When Necessary
Rare:
Abdominal Pain with Cramps, Abnormal Hepatic Function Tests, Acute Pancreatitis, Anaphylaxis, Anorexia, Bone Pain, Conduction Disorder of the Heart, Conjunctivitis, Constipation, Dehydration, Drowsy, Dysgeusia, Erythema Multiforme, Fever, General Weakness, Headache Disorder, Hypercalcemia, Hypercholesterolemia, Hypersensitivity Drug Reactions, Hypertension, Libido Changes, Myalgia, Nausea, Nocturia, Photophobia, Polydipsia, Polyuria, Proteinuria, Pruritus of Skin, Psychotic Disorder, Rhinorrhea, Urinary Tract Infections, Vomiting, Weight Loss, Xerostomia
Most Significant
Hypercalcemia, Hypercalcemia associated with Sarcoidosis, Hypervitaminosis D, Malabsorption States
Significant
Arteriosclerosis Obliterans, Hyperphosphatemia, Kidney Stone, Metastatic Calcification
Possibly Significant
Sarcoidosis
|
